Pr Marc Pocard
- Spécialité
- Chirurgien, expert digestif et thoracique
- Titre
- Directeur d'Unité Carcinose et les pathologies du Péritoine de l'Inserm
- Hôpital
- AP-HP Hôpital Lariboisière (Paris)
- Derniers articles
-
- Correction: Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection. (17 oct. 2025)
- Multisocietal Consensus on the use of Cytoreductive Surgery and HIPEC for the Treatment of Pseudomyxoma Peritonei: A GRADE Approach for Evidence Evaluation and Recommendation. (1 oct. 2025)
- Assessing the Annual Risk of Recurrence Following Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Diffuse Malignant Peritoneal Mesothelioma Patients. (26 sept. 2025)
- Involvement of Hormone Receptors, Membrane Receptors and Signaling Pathways in European Gastric Cancers Regarding Subtypes and Epigenetic Alterations: A Pilot Study. (24 juil. 2025)
- Real-world data on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed therapy in patients with peritoneal metastases; Third annual report from the ISSPP PIPAC database. (10 juin 2025)